BLOG
Today’s 3PL landscape offers more specialized distribution solutions than ever before. Learn how manufacturers can evaluate third-party logistics providers, align capabilities to product needs, and make informed 3PL partner decisions for a successful pharmaceutical product launch.
Learn how to right-size patient support program staffing with data-driven models that balance efficiency, cost, service quality, and patient experience.
How smarter inventory alignment can reduce risk and strengthen supply chain performance.
Healthcare is evolving rapidly, and patient support programs must keep pace.
Manufacturers must now submit ASP data with FMV documentation and BFSF fee certification for Medicare Part B drugs.
Practical, hands-on self-injection training plays a pivotal role in ensuring proper medication use and driving positive patient outcomes.
The pharmaceutical market is evolving fast, and delivering prescriptions efficiently is more challenging than ever. The right pharmacy dispensing strategy can be the difference maker between commercial success and missed opportunities.
By understanding DTC, DTP and the intersection with telemedicine, pharma can deliver more value to patients and drive measurable results.
Proven strategies for mapping and optimizing the patient journey, from diagnosis to ongoing care.
In 2025, digital health is no longer a future consideration—it is a present imperative for key industry players in the pharmaceutical services sector, including manufacturers, specialty pharmacies, payers, and providers
Efficiently managing product returns is a critical lever for controlling costs, minimizing operational inefficiencies, and reducing end-to-end complexity.
Building a coordinated access model is no longer just a difference – it’s a competitive necessity.
Why It Matters and How Archbow Consulting Can Help You Navigate It
A well-designed framework ensures that every step is appropriately structured to eliminate unnecessary delays.
Why Understanding the Product Access Journey is Essential for Patient Support Success
Four Pivotal Trends Revolutionizing Market Access Strategies
How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services
As the only national nonprofit organization representing all specialty pharmacy stakeholders, NASP plays a crucial role in advancing the specialty pharmacy field.
Uncovering insights in the pharmaceutical industry, including optimizing supply chain solutions and refining market access strategies.
Why manufacturers must embrace innovative trends to stay ahead
The 2024 National Association of Specialty Pharmacy (NASP) conference showcased a landscape of rapid innovation and evolving industry trends.
An Interview on Best Practices and Trends in 2025
Discover four essential strategies manufacturers need to transform their Specialty Pharmacy networks into efficient powerhouses to enhance patient care, foster innovative HCP relationships, build robust payer partnerships, and ensure product accessibility.
Designing a pharmaceutical hub for combination or companion products is a complex undertaking that requires careful planning and design execution.
Pharmaceutical manufacturers have many partner choices in today’s competitive Specialty Pharmacy (SP) space. By focusing on the following key areas, SPs can elevate their value proposition and drive mutual success.
Biotech marketing requires a unique blend of scientific expertise, strategic planning, and creative execution.
Navigate the open road ahead with confidence. Start planning today and ensure your 2025 program delivers the support your patients need.
Key Market Access Trends to Watch in 2024
Don’t Let Your Pharma Program Fall Behind – Optimize It Now
The Key to Pharmaceutical Commercial Success
Outlook on Oncology: Key Takeaways from the AVBCC 2023 Educational Summit
Case Study: Fresh Approach to HUB Communications Drives 20% User Growth
HUBs are Underutilized; Yours Doesn’t Have to Be
Key Takeaways from the Health Systems & Pharma Partnering Summit 2023
Risk vs. Reward: A Must-Have Contracting Guide for Specialty Pharmacy Services
Five Takeaways from Medicare’s 10 Drugs Up for Price Negotiation
Pharma Has a Pull-Through Problem; The Answer is Data
As seen in Pharmaceutical Commerce: Key considerations for drug manufacturers pursuing an effective alternative distribution model
The Perils of Pull-Through
6 Essential Strategies for Successful Clinical Adherence
Using Targeted Market Research to Improve Future Adoption of Cell and Gene Therapies
How Pharma Can Turn Data into Insights: Effectively Leveraging Pharma and Market Access Data
Market Access POV: ICER and Specialty Drug Coverage
Good vs. Excellent: How to Maximize Your 3PL Partnership
Key Takeaways from the 2023 Asembia Specialty Pharmacy Summit
How Manufacturers Can Optimize Hub Services
Specialty Pharmacy Services Fair Market Value Benchmark Report
Conversation Starters to Drive Impactful Discussions with Specialty Pharmacies
3PL Health Checks Generate Savings for Manufacturers: Here’s How to Begin
What market access teams should be thinking about after 2023’s SXSW Conference
Manufacturers recognize access and affordability programs as key differentiators that build brand loyalty with elevated customer experiences
Manufacturers recognize access and affordability programs as key differentiators that build brand loyalty with elevated customer experiences
How pharmaceutical manufacturers can efficiently and effectively get product into the hands of patients
Webinar Archive: Get answers to the eleven key questions that will help guide commercial teams in effectively launching specialty products.
With a carefully crafted approach, SPs & Manufacturers can enjoy partnerships that drive access, adherence, and overall program performance
When it comes to pharmacy network design, there is a careful balance between access and control.
Pharmacy dispensing network strategies are an essential linchpin in any product’s commercial success.
For manufacturers who haven’t started preparing for DSCSA D-Day, the “OH NO!” moment is here, but this article can help.
Practical lists of questions spanning distribution, access, and affordability that market access teams can use to impact health equity today
The answers to these eleven questions will help guide commercial teams in effectively launching specialty products.
Poor quality within a HUB can lead to delays in patient treatment, loss of prescriber confidence, and users seeking alternative avenues.
When approached strategically, contracting with SP networks can positively impact patient experience and the company’s bottom line.
It is vital for pharmaceutical manufacturers to consider how much financial and reputational risk they may face as a result of the pending C
We often advise our clients that there are many varied ways to better understand and engage with rare disease patients.